Subscribe to these results:

Upcoming Workshops

For Mantle Cell Lymphoma

  1. Jan31What’s New in Diagnostic Technologies for People Living with Blood Cancers
    Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with CancerRegister

Past workshops

For All Cancers

    1. What’s New in Diagnostic Technologies for People Living with Solid Cancer Tumors
      Part I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer
    3. Understanding Diagnostic Technologies and Biomarkers

For Acute Lymphoblastic Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Acute Myeloid Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Bladder Cancer

    1. Bladder Cancer: Treatment Updates
      Part I of Life with Bladder Cancer

For Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)
      Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    2. What’s New in Diagnostic Technologies for People Living with Solid Cancer Tumors
      Part I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    3. Metastatic Breast Cancer: Treatment Updates

For Chronic Lymphocytic Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Chronic Myelogenous Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Colorectal Cancer

    1. What’s New in Diagnostic Technologies for People Living with Solid Cancer Tumors
      Part I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Colorectal Cancer Treatment: Progress & Advances

For Hodgkin Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Lung Cancer

    1. What’s New in Diagnostic Technologies for People Living with Solid Cancer Tumors
      Part I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Metastatic Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)
      Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    2. Metastatic Breast Cancer: Treatment Updates

For Multiple Myeloma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Myelodysplastic Syndromes

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Myelofibrosis

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Myeloproliferative Neoplasms

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Non-Hodgkin Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Peripheral T-Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Polycythemia Vera

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Small Lymphocytic Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Triple Negative Breast Cancer

    1. Metastatic Breast Cancer: Treatment Updates
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.